Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Lifestyle»Avesthagen’s Teestar® Botanical Chewables Named Finalist For NutraIngredients-Asia 2023 Award Singapore
    Lifestyle

    Avesthagen’s Teestar® Botanical Chewables Named Finalist For NutraIngredients-Asia 2023 Award Singapore

    By August 23, 2023No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Teestar by Avesthagen

    Bangalore (Karnataka) [India], August 23: Teestar® botanical chewables by Avesthagen Limited, a product designed for sugar and weight management, specifically targeting pre-diabetic and diabetic healthcare. Teestar® is a scientifically formulated nutraceutical using all-natural plant-based ingredients. The product has gained recognition as a finalist for the NutraIngredients-Asia 2023 Award and will be showcased at the show at Marina Bay Sands in Singapore on September 26th 2023. 

    With an emphasis on preventive care and general wellness, Avesthagen’s line of bioactive compounds aims to offer naturally occurring, clinically confirmed treatments for numerous disease-specific health issues like Diabetes and Cardiovascular Health. Teestar® chewables are developed to help manage blood sugar levels, particularly after meals, with reported reductions in postprandial blood glucose levels of up to 10 mg/dL. The product also aids in better insulin response.

    Teestar® is formulated from an Indian medicinal plant that has traditionally been a part of the food matrix. The recommended dosage for Teestar® is to consume two chewables before breakfast and dinner daily for optimal results. 

    Dr. Renuka Jain, President of Avesta Nordic Research Pvt. Ltd., explains that Teestar® forms a colloidal-type suspension in the stomach and intestines upon hydration. This leads to slower gastrointestinal transit and digestion of food, resulting in lesser glucose being absorbed from digested food and a prolonged feeling of satiety.

    Teestar® is manufactured in a state-of-the-art production and R&D facility using an eco-friendly and safe extraction process that uses only ethanol and water. Using Avesthagen’s unique fingerprinting method, MetaGrid®, the product’s consistency in quality is maintained.

    Event Showcase: Teestar® Botanical Chewables have been selected as a finalist and are scheduled to be showcased at the Nutra Ingredient Asia Show, which will take place at Marina Bay Sands in Singapore on September 26th, 2023. This event aims to highlight Avesthagen’s ‘Food for Medicine’ program, which is focused on the scientific validation of traditional medicine knowledge and natural plant ingredients leading to plant-based medicines for preventive healthcare and treatment of specific disease conditions.

    Teestar® Botanical Chewables are promoted as a safe and potent calorie modulator that can assist in managing healthy body mass.

    Teestar® is available in two flavors: Litchi and Tamarind, priced at Rs. 750/-. The websites www.avestagoodearthfoods.com, www.amazon.in, and www.1mg.com offer it for sale.

    About Avesthagen: 

    Avesthagen Limited is an international and diversified life sciences company that follows a systems-biology approach. The company is a pioneer in merging the fields of food, pharmaceuticals, and population genetics to create innovative products and therapies. Avesthagen’s focus lies in bringing its developed products and technologies to the market, with a particular emphasis on Nutrigenomics, Agriculture, and Precision Medicine. They utilize their proprietary Predictive, Preventive, and Personalized (“PPP”) healthcare platform to achieve these goals.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    lifestyle
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Power Creator Awards 2026: Ipsita Chowdhury wins Best Pet Friendly Content – Editor’s Choice

    October 26, 2026

    Dharmendra Singh Bhalla: Jaipur’s Master Craftsman Blending Tradition with Innovation

    October 26, 2026

    Beyond the Book: ICA Conclave 2026 Creates New Opportunities for Authors in Goa

    October 26, 2026

    Comments are closed.

    Recent Post
    • RGIPT Celebrates 10th Convocation, Showcases Progress in Research, Innovation and Industry Collaboration
    • ICA | GemLab launches in India, launches gemological laboratory in Surat
    • Kicky & Perky Opens Its First Retail Store at DLF Midtown Plaza, New Delhi
    • Yogesh Sharma (Shelly) Appointed as Chairman, Finance Committee, Paralympic Committee of India (PCI)
    • The 14th Celebrate Cinema 2026 brought together 4,000 creative minds at Whistling Woods International
    • Power Creator Awards 2026: Ipsita Chowdhury wins Best Pet Friendly Content – Editor’s Choice
    • Dharmendra Singh Bhalla: Jaipur’s Master Craftsman Blending Tradition with Innovation
    • Bhatia Mobile Returns to Its Roots in Rohtak; Opens First Haryana Store

    Type above and press Enter to search. Press Esc to cancel.